T cell response to tumor antigens and its therapeutic use in cancer patients.
Parmiani
G
G
Unit of Immunotherapy of Human Cancer, Istituto Nazionale Tumori, Via G. Venezian 1, 20133, Milano, Italy.
Castelli
C
C
Dalerba
P
P
Rivoltini
L
L
D000951:Antigens, Neoplasm / Q000378:metabolism*; D019496:Cancer Vaccines / Q000235:genetics / Q000276:immunology / Q000627:therapeutic use*; D005260:Female; D015395:Histocompatibility Antigens Class I / Q000378:metabolism; D000949:Histocompatibility Antigens Class II / Q000378:metabolism; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000235:genetics / Q000276:immunology* / Q000628:therapy*; D013601:T-Lymphocytes / Q000276:immunology*
D000951:Antigens, Neoplasm; D019496:Cancer Vaccines; D015395:Histocompatibility Antigens Class I; D000949:Histocompatibility Antigens Class II